Live Birth More Likely in ART Cycles With Gestational Carrier

THURSDAY, Oct. 19, 2023 (HealthDay News) -- The likelihood of live birth is increased among assisted reproductive technology cycles with versus without a gestational carrier, according to a research letter published online Oct. 18 in the Journal of the American Medical Association.
Lisa M. Shandley, M.D., from the Emory University School of Medicine in Atlanta, and colleagues describe trends and outcomes in assisted reproductive technology cycles using deidentified data from the Society for Assisted Reproductive Technology Clinic Outcomes Reporting System involving an embryo transfer between 2014 and 2020.
A total of 1,008,205 assisted reproductive technology cycles with an embryo transfer occurred during the study period; 4.0 percent used a gestational carrier. The researchers found that from 2014 to 2019, there was an increase in the absolute number of assisted reproductive technology cycles involving a gestational carrier (2.7 to 5.2 percent), followed by a decrease in 2020 (4.6 percent). Two or more embryos were transferred in 27.6 and 36.0 percent of cycles with versus without a gestational carrier, respectively. Embryo transfers to a gestational carrier were more likely to result in a pregnancy, clinical pregnancy, and live birth (adjusted relative risks, 1.06, 1.09, and 1.11, respectively). The risk for preterm birth and very preterm birth was lower among cycles with versus without a gestational carrier, after adjustment for pregnancy plurality (adjusted relative risks, 0.80 and 0.76, respectively). Of live births, 14.8 and 12.6 percent of cycles with and without a gestational carrier, respectively, resulted in the birth of twins or higher-order multiples (adjusted relative risk, 1.15).
"Although the outcomes appear reassuring, multiple gestation risk is high among cycles with a gestational carrier," the authors write.
Related Posts
¿La marihuana medicinal y el CBD alivian el dolor crónico?
MARTES, 7 de junio de 2022 (HealthDay News) -- El uso de la marihuana medicinal...
El ‘Atlas Celular Humano’ crea un mapa de 1 millón de tipos de células en 33 órganos
JUEVES, 12 de mayo de 2022 (HealthDay News) -- Una iniciativa internacional de...
Retiran los champús en seco de Dove y Tresemme debido a un posible carcinógeno
MARTES, 25 de octubre de 2022 (HealthDay News) -- Unilever anunció el lunes que...
A las personas que toman inmunosupresores les va igual de bien con la COVID grave
LUNES, 22 de noviembre de 2021 (HealthDay News) -- Los pacientes con COVID-19...